in active thyroid eye disease: an effective and well-tolerated treatment option), 12 patients with active TED (7-point scale, CAS ≥ 3 points) ), given 100 mg rituximab infusion and 500 mg intravenous methylprednisolone .
FDA Accepts Precision Therapeutics New Drug Application for Certain Non-Small Cell Lung Cancers
Time of Update: 2022-03-07
S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for poziotinib, a tyrosine kinase inhibitor (TKI), for the treatment of previously treated non-small cell lung cancer (NSCLC) patients with HER2 exon 20 insertion mutations .
Replaying the new crown era, those breakthrough therapeutic drugs that have to be said
Time of Update: 2022-03-06
This review article presents the most impactful breakthrough medical innovations in response to COVID-19, Ebola virus disease (EVD), heart disease, cancer, Alzheimer's disease, diabetes and malaria during the pandemic It has far-reaching significance and positive impact on human beings .
STTT Sichuan University Li Jiong and other teams discover new potential therapeutic targets for colorectal cancer
Time of Update: 2022-02-21
Taken together, our findings highlight the role of IL-37 in harnessing antitumor immunity by inactivating cytotoxic T cells and establish a newly defined suppressor IL-37/SIGIRR in the cancer immune cycle as a treatment for CRC.
mechanism and potential therapeutic target of abnormal blood sugar elevation in patients with new coronary pneumonia
Time of Update: 2022-01-26
/>2020. 04. 021 (2020). 5 Gu, H. et al. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science 369,1603-1607, doi:10. 1126/science. abc4730 (2020).
Alzheimers Dement︱Jinjing Yao et al found a new therapeutic target for Alzheimer's disease
Time of Update: 2022-01-25
Preliminary work in the laboratory of Professor Wayne Chen, University of Calgary, Canada, showed that shortening the open time of RyR2 can prevent and treat AD-related neuronal damage and cognitive decline in AD mouse models (5xFAD+/-).
Hepatology China Pharmaceutical University Yang Yong and other teams discover potential new therapeutic targets for hepatocellular carcinoma
Time of Update: 2022-01-24
(HCC) patients for unknown reasons . Evidence suggests that the interferon signaling pathway plays a critical role in regulating the efficacy and sensitivity of anti-PD-1 therapy
Molecular Cancer Li Gang/Xue Hao of Shandong University discover new potential therapeutic targets for glioma
Time of Update: 2022-01-24
Finally, circNEIL3 was packaged into exosomes by hnRNPA2B1 and delivered to infiltrating tumor-associated macrophages (TAMs), enabling them to acquire immunosuppressive properties by stabilizing IGF2BP3, thereby promoting glioma progression .
New therapeutic target for multiple myeloma
Time of Update: 2022-01-24
"This study provides proof-of-concept that the transposon is a new therapeutic target in multiple myeloma .
A new study provides a new therapeutic target for the treatment of sepsis
Time of Update: 2022-01-24
damage and improve patient outcomes . ">method>Some experiments involved white blood cells isolated from 24 sepsis patients (12 men
"Cell" David Liu's team reports a new tool for in vivo gene editing - the first therapeutic-level virus-like particle!
Time of Update: 2022-01-24
Now, researchers led by a team at the Broad Institute of MIT and Harvard have developed a method to obtain gene-editing proteins inside cells in animal models with high enough efficiency to show therapeutic effects effect .
Genting Sunshine and Providence Therapeutics jointly announced a vaccine development strategy
Time of Update: 2022-01-02
-family:"Arial"; color:black; } p. prnews_p { font-size:0. 62em; font-family:"Arial"; color:black; margin:0in; } Shanghai, China and Calgary , Canada
Good news for patients with metastatic cancer of unknown primary tumor (R) may bring therapeutic benefits
Time of Update: 2022-01-01
is a microarray-based gene expression detection product that can assist in evaluating metastasis The origin of poorly differentiated and undifferentiated tumors in order to improve the treatment benefit of patients with metastatic carcinoma of unknown primary (CUP) .
There are many stories behind the development of my country’s first approved new crown therapeutic
Time of Update: 2021-12-27
The new crown neutralizing antibody drug approved this time was jointly developed by Tsinghua University, Shenzhen Third People's Hospital and Tengsheng Bo Pharmaceutical .
